GT Biopharma Inc (GTBP)
3.12
-0.15
(-4.59%)
USD |
NASDAQ |
May 17, 16:00
3.83
+0.71
(+22.76%)
After-Hours: 20:00
GT Biopharma Net Income (Quarterly): -2.962M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.962M |
| September 30, 2023 | -2.416M |
| June 30, 2023 | -1.992M |
| March 31, 2023 | -0.227M |
| December 31, 2022 | -5.584M |
| September 30, 2022 | -6.881M |
| June 30, 2022 | -2.979M |
| March 31, 2022 | -5.44M |
| December 31, 2021 | -18.02M |
| September 30, 2021 | -5.453M |
| June 30, 2021 | -4.861M |
| March 31, 2021 | -29.68M |
| December 31, 2020 | -6.29M |
| September 30, 2020 | -2.876M |
| June 30, 2020 | -17.42M |
| March 31, 2020 | -1.708M |
| December 31, 2019 | -1.47M |
| September 30, 2019 | -29.88M |
| June 30, 2019 | -2.789M |
| March 31, 2019 | -4.51M |
| December 31, 2018 | -4.231M |
| September 30, 2018 | -235.78M |
| June 30, 2018 | -9.081M |
| March 31, 2018 | -10.09M |
| December 31, 2017 | -6.026M |
| Date | Value |
|---|---|
| September 30, 2017 | -130.62M |
| June 30, 2017 | -2.463M |
| March 31, 2017 | -5.058M |
| December 31, 2016 | -2.829M |
| September 30, 2016 | -3.63M |
| June 30, 2016 | 1.543M |
| March 31, 2016 | 14.68M |
| December 31, 2015 | -26.08M |
| September 30, 2015 | -1.692M |
| June 30, 2015 | 26.86M |
| March 31, 2015 | -20.52M |
| December 31, 2014 | -18.64M |
| September 30, 2014 | -4.22M |
| June 30, 2014 | -0.262M |
| March 31, 2014 | -0.371M |
| December 31, 2013 | -0.354M |
| September 30, 2013 | -0.319M |
| June 30, 2013 | -0.306M |
| March 31, 2013 | 0.468M |
| December 31, 2012 | -0.761M |
| September 30, 2012 | -1.40M |
| June 30, 2012 | -2.395M |
| March 31, 2012 | -0.615M |
| December 31, 2011 | -1.138M |
| September 30, 2011 | 0.023M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-29.88M
Minimum
Sep 2019
-0.227M
Maximum
Mar 2023
-7.838M
Average
-4.861M
Median
Jun 2021
Net Income (Quarterly) Benchmarks
| Cutera Inc | -22.78M |
| Outlook Therapeutics Inc | -114.29M |
| 180 Life Sciences Corp | -1.227M |
| Journey Medical Corp | -10.44M |
| NovaBay Pharmaceuticals Inc | -3.214M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.168M |
| EPS Diluted (Quarterly) | -1.984 |
| Enterprise Value | -9.664M |
| Earnings Yield | -179.0% |